JP2014528699A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014528699A5 JP2014528699A5 JP2014521612A JP2014521612A JP2014528699A5 JP 2014528699 A5 JP2014528699 A5 JP 2014528699A5 JP 2014521612 A JP2014521612 A JP 2014521612A JP 2014521612 A JP2014521612 A JP 2014521612A JP 2014528699 A5 JP2014528699 A5 JP 2014528699A5
- Authority
- JP
- Japan
- Prior art keywords
- felv
- composition
- seq
- polypeptide
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161509912P | 2011-07-20 | 2011-07-20 | |
| US61/509,912 | 2011-07-20 | ||
| PCT/US2012/023658 WO2013012446A1 (en) | 2011-07-20 | 2012-02-02 | Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016212839A Division JP6240294B2 (ja) | 2011-07-20 | 2016-10-31 | 最適化ネコ白血病ウイルスエンベロープ遺伝子を含む組換えネコ白血病ウイルスワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014528699A JP2014528699A (ja) | 2014-10-30 |
| JP2014528699A5 true JP2014528699A5 (enExample) | 2015-01-08 |
| JP6084970B2 JP6084970B2 (ja) | 2017-02-22 |
Family
ID=45722710
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014521612A Active JP6084970B2 (ja) | 2011-07-20 | 2012-02-02 | 最適化ネコ白血病ウイルスエンベロープ遺伝子を含む組換えネコ白血病ウイルスワクチン |
| JP2016212839A Active JP6240294B2 (ja) | 2011-07-20 | 2016-10-31 | 最適化ネコ白血病ウイルスエンベロープ遺伝子を含む組換えネコ白血病ウイルスワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016212839A Active JP6240294B2 (ja) | 2011-07-20 | 2016-10-31 | 最適化ネコ白血病ウイルスエンベロープ遺伝子を含む組換えネコ白血病ウイルスワクチン |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US8895027B2 (enExample) |
| EP (1) | EP2734230B1 (enExample) |
| JP (2) | JP6084970B2 (enExample) |
| CN (1) | CN103957932B (enExample) |
| AU (2) | AU2012284558B2 (enExample) |
| BR (1) | BR112014001287B1 (enExample) |
| CA (1) | CA2842055C (enExample) |
| CY (1) | CY1125328T1 (enExample) |
| DK (1) | DK2734230T3 (enExample) |
| ES (1) | ES2720150T3 (enExample) |
| HR (1) | HRP20190271T1 (enExample) |
| HU (1) | HUE043547T2 (enExample) |
| IL (1) | IL230460B (enExample) |
| IN (1) | IN2014CN00547A (enExample) |
| LT (1) | LT2734230T (enExample) |
| MX (1) | MX351642B (enExample) |
| PL (1) | PL2734230T3 (enExample) |
| PT (1) | PT2734230T (enExample) |
| RS (1) | RS58289B1 (enExample) |
| RU (1) | RU2591817C2 (enExample) |
| SI (1) | SI2734230T1 (enExample) |
| SM (1) | SMT201900129T1 (enExample) |
| TR (1) | TR201901466T4 (enExample) |
| WO (1) | WO2013012446A1 (enExample) |
| ZA (1) | ZA201400349B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015343369B2 (en) | 2014-11-03 | 2018-11-22 | Georgia Tech Research Corporation | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
| EP3691679A2 (en) * | 2017-10-06 | 2020-08-12 | Virbac | Feline vaccines conferring early protection |
| EP3706788A1 (en) * | 2017-11-06 | 2020-09-16 | Intervet International B.V. | Feline leukemia virus vaccine |
| CN111848785B (zh) * | 2020-07-10 | 2022-09-06 | 青岛博隆基因工程有限公司 | 猫疱疹病毒抗体序列、四肽链分子、免疫球蛋白分子 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
| US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
| US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
| US5110587A (en) | 1981-12-24 | 1992-05-05 | Health Research, Incorporated | Immunogenic composition comprising synthetically modified vaccinia virus |
| US4769330A (en) | 1981-12-24 | 1988-09-06 | Health Research, Incorporated | Modified vaccinia virus and methods for making and using the same |
| US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| US5174993A (en) | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
| US5338683A (en) | 1981-12-24 | 1994-08-16 | Health Research Incorporated | Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins |
| US4745051A (en) | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
| EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
| US4963481A (en) | 1985-12-18 | 1990-10-16 | Genetics Institute Inc | Promoter system |
| GB2197321B (en) | 1986-09-12 | 1990-10-03 | Genentech Inc | Method and vectors for obtaining continuous production of heterologous protein in a eukaryotic host cell line |
| IL84154A0 (en) | 1986-10-16 | 1988-03-31 | Microgenesys Inc | Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| DE3743138A1 (de) | 1987-12-18 | 1989-09-14 | Mayr Christian Gmbh & Co Kg | Schleifringlose, elektromagnetische ueberlastkupplung |
| CA2003300A1 (en) | 1988-11-21 | 1990-05-21 | Franklin Volvovitz | Skin test and test kit for aids |
| EP0377842B1 (en) * | 1988-12-13 | 1995-10-04 | President And Fellows Of Harvard College | Prototype FeLV isolates for use in disease models and vaccines |
| US5843456A (en) | 1991-03-07 | 1998-12-01 | Virogenetics Corporation | Alvac poxvirus-rabies compositions and combination compositions and uses |
| EP0575491B1 (en) | 1991-03-07 | 2003-08-13 | Virogenetics Corporation | Genetically engineered vaccine strain |
| US6133028A (en) | 1993-05-28 | 2000-10-17 | Transgene S.A. | Defective adenoviruses and corresponding complementation lines |
| FR2712603B1 (fr) | 1993-11-18 | 1996-02-09 | Centre Nat Rech Scient | Virus recombinants, préparation et utilisation en thérapie génique. |
| US5529780A (en) | 1994-03-30 | 1996-06-25 | Virogenetics Corporation | Nucleotide and amino acid sequences of canine herpesvirus gB and gC |
| JPH11504631A (ja) | 1995-04-25 | 1999-04-27 | バイカル インコーポレイテッド | Ｄｎａ／脂質複合体の単一バイアル製剤 |
| EP0803573A1 (en) | 1996-04-25 | 1997-10-29 | Gesellschaft für Biotechnologische Forschung mbH (GBF) | Polycistronic expression construct with cytokines for multivalent vaccines |
| US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
| AU737243B2 (en) | 1996-07-03 | 2001-08-16 | Merial, Inc. | Recombinant canine adenovirus (CAV) containing exogenous DNA |
| US6156567A (en) | 1996-07-03 | 2000-12-05 | Merial | Truncated transcriptionally active cytomegalovirus promoters |
| US6090393A (en) | 1996-07-03 | 2000-07-18 | Merial | Recombinant canine adenoviruses, method for making and uses thereof |
| FR2775601B1 (fr) | 1998-03-03 | 2001-09-21 | Merial Sas | Vaccins vivants recombines et adjuves |
| FR2776928B1 (fr) | 1998-04-03 | 2000-06-23 | Merial Sas | Vaccins adn adjuves |
| TWI224107B (en) | 1998-10-22 | 2004-11-21 | Pfizer Prod Inc | Novel proteins from actinobacillus pleuropneumoniae |
| US6017537A (en) | 1998-12-18 | 2000-01-25 | Connaught Laboratories, Inc. | Formyl methionyl peptide vaccine adjuvant |
| US6645740B1 (en) | 1999-06-10 | 2003-11-11 | Merial Limited | Nucleic acids encodings equine GM-CSF |
| FR2796397B1 (fr) | 1999-07-16 | 2006-09-01 | Merial Sas | Genes de calicivirus felin et vaccins notamment vaccins recombines |
| WO2001022972A2 (en) | 1999-09-25 | 2001-04-05 | University Of Iowa Research Foundation | Immunostimulatory nucleic acids |
| US6852705B2 (en) | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
| EP1203819A3 (en) | 2000-10-06 | 2002-08-07 | Transgene S.A. | Anti-inflammatory vectors |
| AU2002327338A1 (en) * | 2001-07-25 | 2003-02-17 | New York University | Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| FR2829498B1 (fr) | 2001-09-11 | 2003-11-28 | Merial Sas | Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins |
| WO2003062374A2 (en) | 2001-11-09 | 2003-07-31 | Entremed, Inc. | Synthetic genes for malarial proteins and methods of use |
| AU2003245416A1 (en) | 2002-06-07 | 2004-04-30 | University Of Florida | Endodontic files made using bulk metallic glasses |
| WO2004028562A2 (de) * | 2002-09-23 | 2004-04-08 | Mologen Ag | Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze |
| AU2005229411B2 (en) * | 2004-03-30 | 2010-11-18 | Centre National De La Recherche Scientifique | Polypeptide sequence involved in the modulation of the immunosuppressive effect of viral proteins |
| US7582302B2 (en) | 2004-06-04 | 2009-09-01 | Merial Limited | Needle-free administration of FeLV vaccines |
| US7998733B2 (en) * | 2004-10-05 | 2011-08-16 | Merial Limited | Chimeric vectors |
| ME01965B (me) * | 2005-09-16 | 2012-04-30 | Merial Ltd | Stabilizatori za vakcine osušene zamrzavanjem |
| EP2155883A1 (en) * | 2007-05-30 | 2010-02-24 | Wyeth LLC | Raccoon poxvirus expressing genes of feline antigens |
-
2012
- 2012-02-02 RS RS20190039A patent/RS58289B1/sr unknown
- 2012-02-02 HR HRP20190271TT patent/HRP20190271T1/hr unknown
- 2012-02-02 IN IN547CHN2014 patent/IN2014CN00547A/en unknown
- 2012-02-02 CN CN201280041551.1A patent/CN103957932B/zh active Active
- 2012-02-02 HU HUE12705199A patent/HUE043547T2/hu unknown
- 2012-02-02 AU AU2012284558A patent/AU2012284558B2/en active Active
- 2012-02-02 US US13/364,993 patent/US8895027B2/en active Active
- 2012-02-02 PL PL12705199T patent/PL2734230T3/pl unknown
- 2012-02-02 RU RU2014106295/15A patent/RU2591817C2/ru active
- 2012-02-02 BR BR112014001287-3A patent/BR112014001287B1/pt active IP Right Grant
- 2012-02-02 CA CA2842055A patent/CA2842055C/en active Active
- 2012-02-02 WO PCT/US2012/023658 patent/WO2013012446A1/en not_active Ceased
- 2012-02-02 ES ES12705199T patent/ES2720150T3/es active Active
- 2012-02-02 LT LTEP12705199.3T patent/LT2734230T/lt unknown
- 2012-02-02 SI SI201231522T patent/SI2734230T1/sl unknown
- 2012-02-02 TR TR2019/01466T patent/TR201901466T4/tr unknown
- 2012-02-02 PT PT12705199T patent/PT2734230T/pt unknown
- 2012-02-02 JP JP2014521612A patent/JP6084970B2/ja active Active
- 2012-02-02 MX MX2014000625A patent/MX351642B/es active IP Right Grant
- 2012-02-02 DK DK12705199.3T patent/DK2734230T3/en active
- 2012-02-02 EP EP12705199.3A patent/EP2734230B1/en active Active
- 2012-02-02 SM SM20190129T patent/SMT201900129T1/it unknown
-
2014
- 2014-01-14 IL IL230460A patent/IL230460B/en active IP Right Grant
- 2014-01-16 ZA ZA2014/00349A patent/ZA201400349B/en unknown
- 2014-10-06 US US14/507,455 patent/US9856295B2/en active Active
-
2016
- 2016-10-31 JP JP2016212839A patent/JP6240294B2/ja active Active
-
2017
- 2017-06-26 AU AU2017204298A patent/AU2017204298A1/en not_active Abandoned
-
2019
- 2019-02-14 CY CY20191100209T patent/CY1125328T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA202192570A1 (ru) | Иммуногенные композиции и вакцины, содержащие пептиды и белки вируса африканской чумы свиней, и их применение | |
| HRP20211566T1 (hr) | Antigeni, vektori, pripravci virusa humane imunodeficijencije i postupci njihove uporabe | |
| JP2015096070A5 (enExample) | ||
| RU2015155821A (ru) | Вакцины против малярии | |
| MX2020003176A (es) | Variantes de capsides de virus adenoasociados y metodos de uso de estas. | |
| JP2008529558A5 (enExample) | ||
| JP2013507907A5 (enExample) | ||
| JP2015501840A5 (enExample) | ||
| EA201990718A1 (ru) | Векторы аденовируса собачьих | |
| IL288541B (en) | Vaccine against rsv | |
| FI3872085T3 (fi) | Esimuotoiset virussekvenssit ja niiden käytöt | |
| HRP20130022T1 (hr) | Fuzijski proteini koji sadrže antigene ny-eso-1 i lage-1 za odbacivanje tumora | |
| RU2014135053A (ru) | Иммуногены для вакцинации против вич | |
| JP2016222689A5 (ja) | 合成ペプチド及び乾燥粉末薬剤輸送システム | |
| JP2015186478A5 (enExample) | ||
| MX2021015465A (es) | Vacuna para fiebre porcina africana. | |
| JP2008056679A5 (enExample) | ||
| JP2009544333A5 (enExample) | ||
| EA202090738A1 (ru) | Способ безопасного индуцирования иммунитета против rsv | |
| EA201591213A1 (ru) | Вакцины против вируса гепатита b | |
| JP2014529399A5 (enExample) | ||
| JP2016520534A5 (enExample) | ||
| RU2021109510A (ru) | Вакцинация с использованием альфа 3 домена mica/b для лечения рака | |
| WO2016116905A9 (en) | Cmv antigens and uses thereof | |
| JP2018501258A5 (enExample) |